Providing a wealth of insights drawn from the experience of groundbreaking researchers working in the field, this Second Edition of a landmark volume brings preclinical and clinical studies of Filgrastim (r-metHuG-CSF) up to date with completely revised and expanded discussions of its biology, biochemistry, structure, pharmacology, clinical applications, and pharmacoeconomics.Explores how Filgrastim reduces
infectious complications in the
management of cancer, AIDS, severe chronic neutropenia, neutropenia associated with nonmalignant autoimmune diseases, non-neutropenic infections, lymphoma, leukemia,
diabetic foot infection, and more!Now enhanced with 13 new chapters, Filgrastim